SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001326732-24-000012
Filing Date
2024-04-09
Accepted
2024-04-09 08:20:44
Documents
15
Period of Report
2024-04-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K xncr-20240409.htm   iXBRL 8-K 35233
2 EX-99.1 xncr-20240409xexx991.htm EX-99.1 11037
6 xencora.jpg GRAPHIC 6197
  Complete submission text file 0001326732-24-000012.txt   185476

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xncr-20240409.xsd EX-101.SCH 1898
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xncr-20240409_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xncr-20240409_pre.xml EX-101.PRE 12506
18 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20240409_htm.xml XML 2728
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36182 | Film No.: 24831204
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)